Toxicity Within 6 Months of Heterogeneous Fluorodeoxyglucose-Guided Radiotherapy Dose Escalation for Locally Advanced Non–Small Cell Lung Cancer in the Scandinavian Randomized Phase III NARLAL2 Trial ...

Combination immune checkpoint inhibitor therapy (ICI) with ipilimumab (anti–cytotoxic T-lymphocyte–associated protein 4) + nivolumab (anti–PD-1) in untreated, metastatic melanoma has achieved a ...

Substantial improvements in childhood cancer survival rates have resulted in a growing population of survivors who are living longer. Unfortunately, these survivors carry a substantial burden of ...

Survivorship Care for People Affected by Advanced or Metastatic Cancer: Building on the Recent Multinational Association of Supportive Care in Cancer-ASCO Standards and Practice Recommendations The ...

Over the past two decades, monoclonal antibodies (mAbs) have played a pivotal role in cancer treatment; however, their efficacy as anticancer agents is constrained by tumor heterogeneity and the ...

Since sorafenib's approval in 2008 for advanced HCC, the landscape of systemic therapy remained largely unchanged for nearly a decade, with no breakthroughs emerging during this period. However, in ...

Establishing the Philippine Cancer Center National Cancer Research Agenda 2024-2028: Insights and Future Directions Health care in Jordan is relatively advanced, with a mix of public and private ...

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...

Risk Stratification for Sentinel Lymph Node Positivity in Older Women With Early-Stage Estrogen Receptor–Positive/Human Epidermal Growth Factor Receptor 2 Neu–Negative Invasive Breast Cancer This ...

Educational Video as an Alternative to Pretest In-Person Genetic Counseling in Candidates for Cancer Genetic Testing: A Randomized Controlled Noninferiority Trial The initial data set was compiled ...

Decentralized Point-of-Care Manufacturing of CD19 Chimeric Antigen Receptor T Cells in Mexico This retrospective analysis included patients with WM from September 2002 to September 2023 using the ...

The field of rare cancer research is rapidly transforming, marked by significant progress in clinical trials and treatment strategies. Rare cancers, as defined by the National Cancer Institute, occur ...